Replies to post #1196 on Enanta Pharmaceuticals Inc (ENTA)

[NY1972]

Why this Merck doublet is expected to beat up on V Pak? Based on data released, it can't handle RAVs and doesn't work well @ high VL "one at 948k, 3 between 1-2M iu/ml, 3 between 2-4M, 3 between 4-6M, 3 w VL 6M " .